US Archives - Page 62 of 112 - European Medical Journal

HIV Linked To Threefold Increased Coronary Risk

A recent prospective matched cohort study has revealed that individuals living with HIV (PWH) face a significantly higher risk of developing subclinical coronary atherosclerosis compared to the general population.

Immune Checkpoint Inhibitors: A Balancing Act

Risks of autoimmune conditions (ACs) in patients treated with immune checkpoint inhibitors (ICIs), a critical class of cancer immunotherapies, have been explored in a new epidemiological study.

Combining Oral and UV Therapy for Vitiligo

A recent clinical trial has shown promising results in treating severe, active vitiligo through a combination of oral medication and phototherapy, offering new hope for managing this challenging condition.

New Trial Advances Basal Cell Carcinoma Treatment

A Phase II trial examining neoadjuvant therapy for difficult-to-resect cutaneous basal cell carcinoma (BCC) demonstrates promising outcomes.

Dementia "Diagnosis Unawareness" Highs of 85% in New Study

In Nueces County, Texas, researchers uncovered troubling insights into dementia diagnosis awareness among a diverse population.

High Costs Cause One in Six Adults to Stop Asthma Medication

Financial barriers to asthma medications continue to compromise patient outcomes, increasing the risk of asthma attacks and emergency room visits, according to a recent analysis spanning 2011 to 2022.

Stark Sex Differences in Long COVID Risk

Females are at significantly higher risk of developing long COVID compared to males, according to a recent cohort study involving over 12,000 participants.

Acne Improvements in the First 4 Weeks of Treatment

Fixed-combination topical therapies show improvements in acne within the first 4 weeks of treatment, according to new data compiled from pivotal clinical trials.

Anti-Inflammatory Drugs Linked to Lower Parkinson’s Risk

New research published highlights a potential link between anti-inflammatory treatments and a reduced risk of Parkinson’s disease (PD) in patients with autoimmune disorders.

Checkpoint Myocarditis: A Breakthrough in Immune Insights

Immune checkpoint inhibitors, widely used in cancer therapy, have revolutionized oncology but come with the risk of severe immune-related adverse events, including checkpoint myocarditis.